|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07H 21/02 | (2006.01) |
| A61K 48/00 | (2006.01) | ||
| A61P 21/00 | (2006.01) |
| (11) | Number of the document | 3484524 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17828625.8 |
| Date of filing the European patent application | 2017-07-17 | |
| (97) | Date of publication of the European application | 2019-05-22 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-09 |
| (46) | Date of publication of the claims translation | 2022-12-27 |
| (86) | Number | PCT/US2017/042463 |
| Date | 2017-07-17 |
| (87) | Number | WO 2018/014041 |
| Date | 2018-01-18 |
| (30) | Number | Date | Country code |
| 201662363195 P | 2016-07-15 | US |
| (72) |
RIGO, Frank , US
PRAKASH, Thazha, P. , US
SETH, Punit, P. , US
|
| (73) |
Ionis Pharmaceuticals, Inc. ,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Junginiai ir būdai, skirti SMN2 moduliavimui |
| COMPOUNDS AND METHODS FOR MODULATION OF SMN2 |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 9 | 208.00 EUR |
| 2026-07-17 |